LEXX — Lexaria Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Lexaria Bioscience, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2019 August 31st	R2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1.35	1.31	11.8	6.16	1.48
Net Total Accounts Receivable
Net Total Receivables	0.273	0.209	0.342	0.202	0.175
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.82	1.93	12.4	6.98	2.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.591	0.61	0.459	0.368	0.422
Net Intangible Assets
Total Assets	2.68	2.83	13.3	7.83	3.08
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.185	0.226	0.153	0.194	0.268
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.292	0.303	0.001	-0.115	0.04
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.38	2.53	13.3	7.95	3.04
Total Liabilities & Shareholders' Equity	2.68	2.83	13.3	7.83	3.08
Total Common Shares Outstanding